Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2021

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Michael O'Riordan

October 15, 2021

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

News Conference News TCT 2015

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

October 14, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

Presentation TCT 2014

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Huay Cheem Tan

September 16, 2014

Presentation TCT 2013

Evidence-Based Medicine: Second-Generation DES Are Safer Than BMS and Should Be Used in All Patients During Primary PCI

Presenter: Tullio Palmerini

October 31, 2013

Presentation TCT 2013

US and EU Guideline Similarities and Differences: The Primary PCI Procedure (DES vs. BMS, Thrombus Aspiration, Radial vs. Femoral, and More)

Presenter: Stefan James

October 30, 2013

Presentation TCT 2013

Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective

Presenter: David Cohen

October 28, 2013

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

Presentation TCT 2012

Statement: Second Generation DES Are Safer Than BMS and Should Be Used in All Patients

Presenter: Marco Valgimigli

October 25, 2012

Advertisement

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Live From Denver: TCT 2017, Day Three

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

Novel Devices Present New Treatment Options for STEMI

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

Evidence-Based Medicine: Second-Generation DES Are Safer Than BMS and Should Be Used in All Patients During Primary PCI

US and EU Guideline Similarities and Differences: The Primary PCI Procedure (DES vs. BMS, Thrombus Aspiration, Radial vs. Femoral, and More)

Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Statement: Second Generation DES Are Safer Than BMS and Should Be Used in All Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content